Published in
Elsevier, Immunology Letters, (248), p. 70-77, 2022
DOI: 10.1016/j.imlet.2022.06.009
Links
Tools
Benralizumab reduces eosinophils and inflammatory markers in patients with severe eosinophilic asthma and chronic rhinosinusitis with nasal polyps: A pilot real-life study.
Journal article published in 2022 by
Carlo Cavaliere 
,
Marco Segatto,
Andrea Ciofalo,
Andrea Colizza ,
Antonio Minni,
Daniela Messineo ,
Alessandro Lambiase ,
Antonio Greco,
Marco de Vincentiis,
Simonetta Masieri
,
Marco Segatto,
Andrea Ciofalo,
Andrea Colizza ,
Antonio Minni,
Daniela Messineo ,
Alessandro Lambiase ,
Antonio Greco,
Marco de Vincentiis,
Simonetta Masieri
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 